CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. LEU

Go back to CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.54 -0.11 (6.67%)
Previous Close $1.65    52 Week High $0.66 
Open $1.67    52 Week Low $0.20 
Day High $1.67    P/E N/A 
Day Low $1.54    EPS $-0.34 
Volume 85,823       

CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.54 -0.11 (6.67%)
Previous Close $1.65    52 Week High $0.66 
Open $1.67    52 Week Low $0.20 
Day High $1.67    P/E N/A 
Day Low $1.54    EPS $-0.34 
Volume 85,823